Ms. Pauline McGowan is Senior Vice President of Finance of Topo Therapeutics. She is an experienced biotechnology finance executive with more than 25 years of financial and operational leadership experience, specializing in building and scaling finance organizations at high-growth life sciences companies. Throughout her career, Ms. McGowan has held senior leadership positions at Tome Biosciences, Cygnal Therapeutics, Ginkgo Bioworks, and Concert Pharmaceuticals, helping build and scale organizations through financings, strategic transactions, public company readiness, and periods of rapid growth. Earlier in her career, she held finance and accounting leadership roles at several biotechnology companies and began her career with PricewaterhouseCoopers. Ms. McGowan earned a Bachelor of Science in Business Administration from Villanova University.